Krause Sandra, Capito Florian, Oeinck Verena, Flato Hendrik, Hoffmann Holger, Ötes Ozan, Berg Annette
Sanofi-Aventis Deutschland GmbH, R&D Biologics Development -Purification Development, Industriepark Höchst, 65926, Frankfurt am Main, Germany.
Sanofi-Aventis Deutschland GmbH, R&D Microbial Platform Bioprocess Engineering, Industriepark Höchst, 65926, Frankfurt am Main, Germany.
Biotechnol Notes. 2024 Mar 26;5:50-57. doi: 10.1016/j.biotno.2024.03.001. eCollection 2024.
During manufacturing of mammalian-cell derived monoclonal antibodies (mAbs) virus clearance capacity of the downstream process has to be demonstrated. The protein A chromatography step typically achieves less than 4 log and is not considered as a major contributing step. Having been successfully applied to host cell protein removal before, we used different wash buffers for three mAbs with two model viruses (Minute virus of mice and Murine leukemia virus) in series as well as separately to further understand major contributing interactions for virus retention and potentially design a generic toolbox of stringent wash buffers to be applied to various mAbs. Results indicate a major relevance of hydrophobic interaction for Murine leukemia virus (xMuLV) and mAb A, based on improved clearance for buffers additionally containing increased levels of hydrophobic compounds. This effect was less pronounced for Minute virus of mice (MVM), whereby hydrogen-bonds were expected to play a stronger role for this model virus. Additionally, electrostatic interactions presumably are more relevant for MVM retention compared to xMuLV under the conditions evaluated. A generic mAb and virus-independent stringent wash buffer toolbox could not be identified. However, based on our results a customized mAb and virus wash buffer design with improved virus clearance is possible, with here demonstrated log reduction increase by 1.3 log for MVM and 2.2 log for xMuLV for the protein A step compared to equilibration buffer alone.
在生产哺乳动物细胞衍生的单克隆抗体(mAb)时,必须证明下游工艺的病毒清除能力。蛋白A层析步骤通常实现的病毒清除率低于4个对数,因此不被视为主要的贡献步骤。鉴于之前已成功应用于宿主细胞蛋白去除,我们使用不同的洗涤缓冲液,分别或串联处理三种单克隆抗体与两种模型病毒(小鼠微小病毒和鼠白血病病毒),以进一步了解病毒保留的主要作用机制,并有可能设计一个通用的严格洗涤缓冲液工具箱,用于各种单克隆抗体。结果表明,基于额外含有更高水平疏水化合物的缓冲液对病毒清除率的提高,疏水相互作用对鼠白血病病毒(xMuLV)和单克隆抗体A具有重要意义。对于小鼠微小病毒(MVM),这种影响不太明显,预计氢键对该模型病毒起更强的作用。此外,在所评估的条件下,与xMuLV相比,静电相互作用可能与MVM的保留更相关。未能确定一个通用的、与单克隆抗体和病毒无关的严格洗涤缓冲液工具箱。然而,根据我们的结果,有可能设计出一种定制的单克隆抗体和病毒洗涤缓冲液,提高病毒清除率,与单独的平衡缓冲液相比,在此证明蛋白A步骤对MVM的对数减少增加了1.3个对数,对xMuLV增加了2.2个对数。